Literature DB >> 25151563

Antiretroviral therapy: when to start.

Christopher J Sellers1, David A Wohl2.   

Abstract

In this article, the scientific evidence and professional guidelines regarding the timing of antiretroviral therapy initiation are reviewed, with discussion of the increasingly persuasive evidence in favor of starting treatment early in the course of human immunodeficiency virus disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiretroviral; CD4; Human immunodeficiency virus; Initiation; Start; Therapy; Timing

Mesh：

Substances：

Year:  2014        PMID： 25151563      PMCID： PMC4369085          DOI： 10.1016/j.idc.2014.05.004

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  69 in total

1.  Complicated atazanavir-associated cholelithiasis: a report of 14 cases.

Authors:  Soloniaina Rakotondravelo; Yves Poinsignon; Françoise Borsa-Lebas; Arnaud de la Blanchardière; Christophe Michau; Hélène Jantzem; Nathalie Massy; Elisabeth Polard; Fanny Giroux; Hélène Kerspern; Ahmed Meskar; Guy Hue; Olivier Tribut; Cédric Arvieux; Pierre Tattevin
Journal:  Clin Infect Dis       Date:  2012-07-19       Impact factor: 9.079

2.  Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

Authors:  Roger J Bedimo; Andrew O Westfall; Henning Drechsler; Gabriela Vidiella; Pablo Tebas
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

3.  Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.

Authors:  Christoph G Lange; Michael M Lederman; Juan Sierra Madero; Kathy Medvik; Robert Asaad; Christina Pacheko; Claudia Carranza; Hernan Valdez
Journal:  J Acquir Immune Defic Syndr       Date:  2002-05-01       Impact factor: 3.731

4.  Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

Authors:  Kehmia Titanji; Francesca Chiodi; Rino Bellocco; Danika Schepis; Lyda Osorio; Chiara Tassandin; Giuseppe Tambussi; Sven Grutzmeier; Lucia Lopalco; Angelo De Milito
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

5.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

6.  Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2013-01-03       Impact factor: 4.897

7.  Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Authors:  Signe Westring Worm; Caroline Sabin; Rainer Weber; Peter Reiss; Wafaa El-Sadr; Francois Dabis; Stephane De Wit; Matthew Law; Antonella D'Arminio Monforte; Nina Friis-Møller; Ole Kirk; Eric Fontas; Ian Weller; Andrew Phillips; Jens Lundgren
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

8.  No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

Authors:  Marlous L Grijsen; Radjin Steingrover; Ferdinand W N M Wit; Suzanne Jurriaans; Annelies Verbon; Kees Brinkman; Marchina E van der Ende; Robin Soetekouw; Frank de Wolf; Joep M A Lange; Hanneke Schuitemaker; Jan M Prins
Journal:  PLoS Med       Date:  2012-03-27       Impact factor: 11.069

9.  British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.

Authors:  Ian Williams; Duncan Churchill; Jane Anderson; Marta Boffito; Mark Bower; Gus Cairns; Kate Cwynarski; Simon Edwards; Sarah Fidler; Martin Fisher; Andrew Freedman; Anna Maria Geretti; Yvonne Gilleece; Rob Horne; Margaret Johnson; Saye Khoo; Clifford Leen; Neal Marshall; Mark Nelson; Chloe Orkin; Nicholas Paton; Andrew Phillips; Frank Post; Anton Pozniak; Caroline Sabin; Roy Trevelion; Andrew Ustianowski; John Walsh; Laura Waters; Edmund Wilkins; Alan Winston; Mike Youle
Journal:  HIV Med       Date:  2012-09       Impact factor: 3.180

10.  When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Authors:  Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391
View more
  3 in total

1.  Current Status Towards 90-90-90 UNAIDS Target and Factors Associated with HIV Viral Load Suppression in Kediri City, Indonesia.

Authors:  Geofrey Ssekalembe; Muhammad Atoillah Isfandiari; Hendick Suprianto
Journal:  HIV AIDS (Auckl)       Date:  2020-01-16

2.  Human Immunodeficiency Virus (HIV) and Aging: Multimorbidity in Older People With HIV in One Nonurban Southeastern Ryan White HIV/AIDS Program Clinic.

Authors:  Elizabeth C Arant; Ceshae Harding; Maria Geba; Paul V Targonski; Kathleen A McManus
Journal:  Open Forum Infect Dis       Date:  2020-12-05       Impact factor: 3.835

3.  Differential Self-Reported Determinants to Antiretroviral Therapy Adherence: Findings from Caregivers of Children Under Five Years Living with Human Immunodeficiency Virus Infection Attending Al-Sabah Hospital, South Sudan.

Authors:  Peter Deng Tong; Christine Atuhairwe; Ivan Mugisha Taremwa
Journal:  HIV AIDS (Auckl)       Date:  2020-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.